Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis

被引:9
作者
Bales, John R. R. [1 ]
Kim, Haesook T. T. [2 ]
Portillo, Roxana [1 ]
Patel, Chirayu [3 ]
McAfee, Steven [4 ]
Dey, Bimalangshu [4 ]
Spitzer, Thomas [4 ]
Chen, Yi-Bin [4 ]
El-Jawahri, Areej [4 ]
DeFilipp, Zachariah [4 ]
Hobbs, Gabriela S. S. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Hematopoiet Cell Transplant & Cellular Therapy Pro, Boston, MA USA
关键词
NEOPLASMS; SPLEEN;
D O I
10.1038/s41409-023-01913-9
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:459 / 461
页数:3
相关论文
共 12 条
  • [1] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert
    Thiele, Jurgen
    Borowitz, Michael J.
    Le Beau, Michelle M.
    Bloomfield, Clara D.
    Cazzola, Mario
    Vardiman, James W.
    [J]. BLOOD, 2016, 127 (20) : 2391 - 2405
  • [2] Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type
    Bacigalupo, A.
    Soraru, M.
    Dominietto, A.
    Pozzi, S.
    Geroldi, S.
    Van Lint, M. T.
    Ibatici, A.
    Raiola, A. M.
    Frassoni, F.
    De Stefano, F.
    Verdiani, S.
    Casarino, L.
    Barosi, G.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 (03) : 458 - 463
  • [3] Morbidity and Mortality Following Elective Splenectomy for Benign and Malignant Hematologic Conditions Analysis of the American College of Surgeons National Surgical Quality Improvement Program Data
    Bagrodia, Naina
    Button, Anna M.
    Spanheimer, Philip M.
    Belding-Schmitt, Mary E.
    Rosenstein, Lori J.
    Mezhir, James J.
    [J]. JAMA SURGERY, 2014, 149 (10) : 1022 - 1029
  • [4] Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment
    Gergis, Usama
    Kuriakose, Emil
    Shore, Tsiporah
    Mayer, Sebastian
    Mark, Tomer
    Pearse, Roger
    Schuster, Michael
    Feldman, Eric
    Roboz, Gail
    Ritchie, Ellen
    Scandura, Joseph
    Wang, Hanhan
    Zhou, Xi Kathy
    Silver, Richard T.
    van Besien, Koen
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (05) : 297 - 303
  • [5] Survival following allogeneic transplant in patients with myelofibrosis
    Gowin, Krisstina
    Ballen, Karen
    Ahn, Kwang Woo
    Hu, Zhen-Huan
    Ali, Haris
    Arcasoy, Murat O.
    Devlin, Rebecca
    Coakley, Maria
    Gerds, Aaron T.
    Green, Michael
    Gupta, Vikas
    Hobbs, Gabriela
    Jain, Tania
    Kandarpa, Malathi
    Komrokji, Rami
    Kuykendall, Andrew T.
    Luber, Kierstin
    Masarova, Lucia
    Michaelis, Laura C.
    Patches, Sarah
    Pariser, Ashley C.
    Rampal, Raajit
    Stein, Brady
    Talpaz, Moshe
    Verstovsek, Srdan
    Wadleigh, Martha
    Agrawal, Vaibhav
    Aljurf, Mahmoud
    Angel Diaz, Miguel
    Avalos, Belinda R.
    Bacher, Ulrike
    Bashey, Asad
    Beitinjaneh, Amer M.
    Cerny, Jan
    Chhabra, Saurabh
    Copelan, Edward
    Cutler, Corey S.
    DeFilipp, Zachariah
    Gadalla, Shahinaz M.
    Ganguly, Siddhartha
    Grunwald, Michael R.
    Hashmi, Shahrukh K.
    Kharfan-Dabaja, Mohamed A.
    Kindwall-Keller, Tamila
    Kroeger, Nicolaus
    Lazarus, Hillard M.
    Liesveld, Jane L.
    Litzow, Mark R.
    Marks, David, I
    Nathan, Sunita
    [J]. BLOOD ADVANCES, 2020, 4 (09) : 1965 - 1973
  • [6] Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data
    Loscocco, Giuseppe G.
    Guglielmelli, Paola
    Vannucchi, Alessandro M.
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 12367 - 12382
  • [7] Ponce SB, 2022, ADV RADIAT ONCOL, V7
  • [8] Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome
    Shimomura, Yoshimitsu
    Hara, Masahiko
    Katoh, Daisuke
    Hashimoto, Hisako
    Ishikawa, Takayuki
    [J]. ANNALS OF HEMATOLOGY, 2018, 97 (06) : 1049 - 1056
  • [9] Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management
    Tefferi, Ayalew
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (01) : 145 - 162
  • [10] Mutations and prognosis in primary myelofibrosis
    Vannucchi, A. M.
    Lasho, T. L.
    Guglielmelli, P.
    Biamonte, F.
    Pardanani, A.
    Pereira, A.
    Finke, C.
    Score, J.
    Gangat, N.
    Mannarelli, C.
    Ketterling, R. P.
    Rotunno, G.
    Knudson, R. A.
    Susini, M. C.
    Laborde, R. R.
    Spolverini, A.
    Pancrazzi, A.
    Pieri, L.
    Manfredini, R.
    Tagliafico, E.
    Zini, R.
    Jones, A.
    Zoi, K.
    Reiter, A.
    Duncombe, A.
    Pietra, D.
    Rumi, E.
    Cervantes, F.
    Barosi, G.
    Cazzola, M.
    Cross, N. C. P.
    Tefferi, A.
    [J]. LEUKEMIA, 2013, 27 (09) : 1861 - 1869